Fact CheckerSign in

NCT05646589Completed

A Person-centred Care Transition Support for People With Stroke/TIA

Implementation and Evaluation of a Person-centred Care Transition Support for People With Stroke/TIA

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

The goal of this clinical trial is to test a person-centred care transition support in people with stroke/TIA. The main questions it aims to answer are: * Does a multi-component care transition intervention have an effect on perceived quality of care transitions, health literacy, collected medications, medication adherence, perceived person-centeredness, functioning, recurrent stroke/TIA, healthcare utilization and caregiver burden? * What are the experiences of the intervention components and the implementation process? * How does the intervention get adapted and implemented in practice? * What contextual moderators and mechanisms of the intervention can likely explain the potential effects of the intervention? Participants will receive a person-centred care transition support that includes a set of activities targeting how healthcare professionals can improve quality with care transition and support health literacy for self-management of secondary stroke prevention for persons who are to be discharged from hospitals after stroke or TIA. Researchers will compare participants who receive the person-centred care transition support with participants receiving regular care transitions to see if the person-centred care transition support has any effects on perceived quality of care transitions, health literacy, collected medications, medication adherence, perceived person-centeredness, functioning, recurrent stroke/TIA, healthcare utilization and caregiver burden.

Status (registry)
Completed
Study type
Interventional
Enrollment
213 (actual)
First submitted
2 Dec 2022
Start date
21 Nov 2022
Primary completion date
27 Oct 2024
Lead sponsor
Karolinska Institutet
Diseases
Stroke
NCT number
NCT05646589

What you commit to

  • Study type: Interventional
  • Participants enrolled: 213
  • From 21 Nov 2022 to the primary completion date, 27 Oct 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • unable to give informed consent, due to e.g., severe aphasia or dementia.

Who the study is looking for

  • patients who have had a first time ever or recurrent stroke or TIA; who are to be discharged from the participating hospitals to home and referred to a neurorehabilitation team for continued rehabilitation; and who are able to give informed consent by themselves.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aleris Dalengeriatriken
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status
Danderyd Hospital
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status
Södersjukhuset
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.